Doc, you are correct that I misinterpreted Thermo's holdings. However, he has not "made" anything until he sells, and I know you know that. Since he claims to have not sold a share, then my point stills stands. He may be a strong believer in the science of DCVax, as I believe most of us are, but he is also putting his trust for the future of his rather large investment in the management of this company. Yes, the value of his investment has climbed on paper, but until he sells he hasn't made a dime, and that means he's still trusting these people. He hasn't cashed in his chips; he's still rolling the dice.
I sold some at $1.72 a couple of weeks ago, but I'm also still holding a sizeable chunk because I think it's going to pop at least one more time before they disappoint us. It may even pop into the $2.50-$3.00 range if we are lucky. Anyone who is still holding after that is going to be in for a rude surprise because, as I have said a thousand times, the people running this company have shown themselves to be liars and the only thing they know how to do is disappoint. That's the pattern they have established over the last seven, eight, nine years or more. Constant disappointment. That's who they are. That's what they do. It's not going to change.
That's the point I was making. There is a major disconnect with many of the people who post here who cannot see that there are two distinct elements to drug approval. The product may be great, but you have to have competent people to get it through the approval process. The approval process for DCVax has been missing competent people since the beginning (Dr. Liau is competent, but she is not NWBO and she is not involved in the approval process). If you can't prove the drug is great, then nothing else matters.
There are people here arguing I should be grateful for making some profit at $1.72, but that's not why I invested in this company seven years ago. It took me seven years of averaging down before I could get to a point where I could make a profit at $1.72. The promise here and the hype here has always been about something far greater than $1.72, but after all this time it has become quite clear that those higher expectations will never be realized because of the people in charge of proving DCVax works. All they do is disappoint.
AI
